NM_002471.4:c.5137G>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_002471.4(MYH6):c.5137G>A(p.Glu1713Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1713Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_002471.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 14Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
- Keppen-Lubinsky syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- atrial septal defect 3Inheritance: AD Classification: LIMITED Submitted by: G2P
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MYH6 | NM_002471.4 | c.5137G>A | p.Glu1713Lys | missense_variant | Exon 34 of 39 | ENST00000405093.9 | NP_002462.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000526  AC: 8AN: 152192Hom.:  0  Cov.: 30 show subpopulations 
GnomAD2 exomes  AF:  0.0000320  AC: 8AN: 250104 AF XY:  0.0000148   show subpopulations 
GnomAD4 exome  AF:  0.0000130  AC: 19AN: 1461884Hom.:  0  Cov.: 33 AF XY:  0.0000110  AC XY: 8AN XY: 727242 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000526  AC: 8AN: 152192Hom.:  0  Cov.: 30 AF XY:  0.0000269  AC XY: 2AN XY: 74344 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 14    Uncertain:1 
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1713 of the MYH6 protein (p.Glu1713Lys). This variant is present in population databases (rs369275573, gnomAD 0.02%). This missense change has been observed in individual(s) with left ventricular noncompaction (PMID: 32183154). ClinVar contains an entry for this variant (Variation ID: 263451). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MYH6 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided    Uncertain:1 
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35621855, 32183154, 33309763) -
Cardiovascular phenotype    Uncertain:1 
The p.E1713K variant (also known as c.5137G>A), located in coding exon 32 of the MYH6 gene, results from a G to A substitution at nucleotide position 5137. The glutamic acid at codon 1713 is replaced by lysine, an amino acid with similar properties. This variant has been detected in an individual from a left ventricular non-compaction cohort (Hirono K et al. J Clin Med, 2020 Mar;9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at